GlycoMimetics lowers size of IPO

|About: GlycoMimetics (GLYC)|By:, SA News Editor

GlycoMimetics (GLYC) has cut the proposed size of its Nasdaq IPO to $46M from a previous plan of $56-64M and lowered the offer price to $8 a share from $14-16.

However, the biotech, which develops treatments for sickle cell episodes and acute myeloid leukemia (AML), has increased the number of shares it intends to sell to 5.8M from 4M. (S-1)